Home MSD Animal Health Receives Positive Final Opinion from European Medicines Agency for BRAVECTO (fluralaner) Spot-On for Cats and Dogs
 

Keywords :   


MSD Animal Health Receives Positive Final Opinion from European Medicines Agency for BRAVECTO (fluralaner) Spot-On for Cats and Dogs

2016-03-22 09:00:00| Merck.com - Corporate News

Dateline City: MADISON, N.J. Only Spot-On Treatment for Fleas and Ticks Effective For 12 Weeks MADISON, N.J.--(BUSINESS WIRE)--MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency has adopted a positive final opinion, recommending the granting of a marketing authorization for the veterinary medicinal product BRAVECTO (fluralaner) Spot-On for both cats and dogs. Language: English Contact: MSD Animal HealthMedia:Amy Firsching, +1-908-473-6357amy.firsching@merck.comorPam Eisele, +1-908-423-5042pamela_eisele@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: health final positive opinion

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.11Subtropical Storm Patty Graphics
02.11Subtropical Storm Patty Forecast Discussion Number 1
02.11Subtropical Storm Patty Wind Speed Probabilities Number 1
02.11Subtropical Storm Patty Forecast Advisory Number 1
02.11Subtropical Storm Patty Public Advisory Number 1
02.11Summary for Subtropical Storm Patty (AT2/AL172024)
02.11Tropical Storm Lane Graphics
02.11Tropical Storm Lane Forecast Discussion Number 3
More »